InvestorsHub Logo
icon url

ProfitScout

05/14/07 3:46 PM

#42 RE: Kinwoep #41

Strong bounce back in response to the PR today. The share price drop was totally unjustified and smart investors are taking advantage of the bargain here while it lasts. Glad the company was on top of things and issued their statements today.
icon url

Hedge Starz

06/10/12 10:47 PM

#123 RE: Kinwoep #41

AccelPath is currently focused on the $14 billion anatomic pathology market in the US. The Company's business model builds upon the expertise of experienced pathologists to provide seamless, reliable and comprehensive pathology and special test offerings to referring physicians using conventional and digital technologies. The Company establishes longstanding relationships with the referring physicians as a result of focused delivery of its partner's diagnostic services, personalized responses and frequent consultations, and its proprietary flexible information technology, or IT, solutions that are customizable to the referring physicians' or laboratories as well as the pathologists' needs. Such diagnostic reports often enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patients' health in a cost-effective manner. AccelPath's IT and communications platform enables it to efficiently and securely deliver diagnostic reports to referring physicians. In addition, AccelPath's IT platform enables close tracking and monitoring of medical statistics.
AccelPath is focused on the design, research, development and integration of three-dimensional imaging devices and systems primarily in the healthcare industries which it contributes to the Company. The Company will also exploit its three-dimensional imaging technology for use in intelligent surveillance devices and systems, as well as three-dimensional facial recognition systems for security and law enforcement agencies thru future strategic partnerships. Historically, the Company's largest customers have been the National Institutes of Health and the Department of Defense.
Additional Company information may be found on the Internet at:
www.accelpath.com.